Upton Law Firm is investigating the dialysis products GranuFlo and NaturaLyte. These products have been linked to an increased risk of heart disease and death. According to a New York Times article, the manufacturer, Fresenius Medical Care, was aware of the dangers associated with these products but failed to warn patients and doctors. The company’s actions have placed more than half of all dialysis patients in the United States at risk.
This new alliance gives Upton Law Firm access to the unparalleled expertise of Dialysis Advocates and its leader Arlene Mullin. Mullin has been at the forefront of dialysis care issues for over 15 years and played a key role in hearings on the dialysis industry before the U.S. Senate.
William Tinker, COO and spokesperson for Dialysis Advocates, said the new alliance will “pursue justice for patients injured during dialysis and advocate for better dialysis care.”
About Upton Law Firm
Upton Law Firm represents clients who have been harmed by the wrongdoing of others. The Firm helps clients throughout the country who have been damaged physically, emotionally, or financially. It takes pride in standing beside people through the most difficult times in their lives. While recognizing that the legal system cannot undo past harms, Upton Law Firm helps clients receive the maximum compensation they are entitled to under the law. For more information, please visit www.uptonfirm.com.
About Dialysis Advocates
Dialysis Advocates fights to improve the dialysis process for patients. From clinic staff and management issues, to regional oversight and corporate policies, Dialysis Advocates has a stellar record of results on behalf of patients. At the federal level, it regularly confers with Medicare officials about problematic conditions in clinics, following through until satisfactory resolution is achieved. Quality patient care is the ultimate goal. For more information, please visit www.dialysisadvocates.com.
Note to media: High-resolution images and interviews available upon request.
